Bio-economy and the commercialisation of ART 

Precongress Course 6

 
SIG Global and Socio-cultural aspects of (in)fertility


Course type

Basic



Course co-ordinators

Willem Ombelet (Belgium), Virginie Rozée (France), Trudie Gerrits (The Netherlands), Françoise Shenfield (United Kingdom)



Course description

The development of ART has been accompanied for many years by growing globalisation and commercialisation. Several aspects include patchy state funding with a public/private disparity and increased competition, the growth of cross border reproductive care, and the compensation or remuneration in “third party” ART whether by gametes donation or surrogacy that creates a kind of new reproductive labour and a parallel bio-economy.

This context raises many issues in terms of accessibility, (in)equalities, risks and benefits both for our patients, third parties involved (donors and surrogates) and policy makers .
The objective of this precongress course is to analyse some issues raised by the commercialisation of ART with specific examples and to discuss some models which might best benefit different patients who need fertility care.



Target audience

Clinicians, nurses, scientists, psychologists, counsellors, social workers, researchers, managers, health care providers.



Educational needs and expected outcomes

To analyse the impact and consequences of commercialisation of reproductive medicine for patients, practitioners, health care providers, health care and society in general. The expected outcome is to critically analyse commercialisation in ART.

 

Programme




Monday 06 July 2020

09:00 - 09:30
The baby business: Commerce and regulation in the assisted reproduction industry
Debora Spar, U.S.A.
09:30 - 09:45
Discussion
09:45 - 10:15
Patenting foundational technologies: Lessons from CRISPR and other core biotechnologies
Speaker to be announced
10:15 - 10:30
Discussion
10:30 - 11:00
Coffee break
11:00 - 11:30
The risks and benefits of add-ons in IVF programmes
Tarek El-Toukhy, United Kingdom
11:30 - 11:45
Discussion
11:45 - 12:15
Introducing affordable IVF: Dreams versus nightmares
Willem Ombelet, Belgium
12:15 - 12:30
Discussion
12:30 - 13:30
Lunch break
Solutions worldwide
13:30 - 14:00
The ethics of commercialisation in assisted reproduction
Françoise Shenfield, United Kingdom
14:00 - 14:15
Discussion
14:15 - 14:45
Can surrogacy be non commercial? An international overview
Virginie Rozée, France
14:45 - 15:00
Discussion
15:00 - 15:30
Coffee break
15:30 - 16:00
Direct-to-consumer advertising of success rates in ART: Risks of selective reporting
Jack Wilkinson, United Kingdom
16:00 - 16:15
Discussion
16:15 - 16:45
Industry and assisted reproduction: Ain't no sunshine
Cindy M. Farquhar, New Zealand
16:45 - 17:00
Discussion